Florida’s monoclonal antibody plan cost $244.8 million in 2021

Lawmakers were asked to set aside another $634.3 million for future coronavirus surges.
The monoclonal antibody treatments will be paid for by reimbursement from the Federal Emergency Management Agency.
The monoclonal antibody treatments will be paid for by reimbursement from the Federal Emergency Management Agency.
Published Nov. 4, 2021|Updated Nov. 4, 2021

TALLAHASSEE — On Thursday, Florida officials gave a price tag to the state’s monoclonal antibody program for this year: $244 million in federal money.

That’s how much it’s expected to cost to set up and operate 25 state-run monoclonal antibody sites. Once 2021 turns to 2022, state officials say they could need another $634.3 million in order to meet the demand for various antiviral treatments, including other monoclonal antibody therapies.

The COVID-19 treatments will ultimately be paid for by reimbursement from the Federal Emergency Management Agency. On Thursday, a state official asked a panel of lawmakers charged with overseeing the state’s budget for the authority to draw down those federal funds.

The $244.8 million budget request would pay for the monoclonal antibody treatment program launched by the state in early August. Gov. Ron DeSantis has claimed that the program saved thousands of Floridians from hospitalization during the worst COVID-19 surge on record. However, the Department of Health has not released detailed figures on how many Floridians have gotten the treatment, despite months of inquiries from the Times/Herald. As he started pushing monoclonal antibodies, DeSantis placed less emphasis on coronavirus vaccines, which are widely available, free, safe and effective at preventing the worst effects of the disease.

Lawmakers were asked to set aside another $634.3 million in case the state ends up needing more medications for a future coronavirus surge.

“This authority should give us enough head room should there be another spike, should we need to increase the antivirals and use something besides Regeneron,” said Mark Mahoney, a financial management administrator at the Florida Division of Emergency Management, on Thursday.

Mahoney said the Department of Health arrived at the $634.3 million estimate by projecting the needs of the state’s monoclonal antibody treatment sites during a future potential surge. GlaxoSmithKline’s monoclonal treatment, sotrovimab, costs $2,100 per dose. A dose of Regeneron’s monoclonal antibody treatment costs the same amount. However, the federal government owns the supply of that treatment, and they offer it to states for free. Florida would only need the additional money if the state were to run out of Regeneron’s treatments. (The monoclonal antibody treatments are offered at the state sites at no cost to the patient.)

The state could also use that extra money to buy any future pharmaceuticals that are eligible for reimbursement from the Federal Emergency Management Agency. That means Florida could theoretically buy doses of antiviral pills like molnupiravir, which the United Kingdom approved on Thursday, once the U.S. government gives that treatment the green light.

DeSantis has already used some federal funds to buy additional monoclonal antibody doses. In September, when the federal government cut back Florida’s supply of the Regeneron treatment, DeSantis moved to acquire 3,000 doses of sotrovimab. At the time, DeSantis said he made the move to avoid any monoclonal antibody shortages in the state.

Keep up with Tampa Bay’s top headlines

Keep up with Tampa Bay’s top headlines

Subscribe to our free DayStarter newsletter

We’ll deliver the latest news and information you need to know every morning.

You’re all signed up!

Want more of our free, weekly newsletters in your inbox? Let’s get started.

Explore all your options

But by late September, when he made that move, COVID-19 cases had already been falling for weeks. The monoclonal antibody shortages never materialized. On Wednesday, the federal government reported that Florida’s hospitals had used just 627 doses of Regeneron’s monoclonal antibody treatment in the past week — the lowest figure since the federal government started tracking the statistic in July.

Related: DeSantis prediction of Florida monoclonal antibody shortage hasn’t come true

• • •

Tampa Bay Times coronavirus coverage

DELTA VARIANT: The contagious variant has changed what we know about staying safe from COVID-19. Here's what you need to know.

KIDS AND COVID: Kids are back in school, but COVID-19 is still a problem. Here's what parents and kids need to know.

SENIORS AND COVID: Here’s how seniors can stay safe from the virus.

IT'S FLU SEASON: Get a flu shot and the COVID vaccine to avoid a ‘twindemic.’

VACCINES Q&A: Have coronavirus vaccine questions? We have answers, Florida.

GET THE DAYSTARTER MORNING UPDATE: Sign up to receive the most up-to-date information.

A TRIBUTE TO FLORIDIANS TAKEN BY THE CORONAVIRUS: They were parents and retirees, police officer and doctors, imperfect but loved deeply.

HAVE A TIP?: Send us confidential news tips.

We’re working hard to bring you the latest news on the coronavirus in Florida. This effort takes a lot of resources to gather and update. If you haven’t already subscribed, please consider buying a print or digital subscription.